Skip to main content
OpenTrials

Clinical trial condition

Neoplasms by Histologic Type

Explore clinical trials studying Neoplasms by Histologic Type. Study availability and eligibility vary by location and protocol.

30,134 public trials 6,478 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms by Histologic Type trial results

Recruiting

A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer

NCT06385080

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +5 more
Locations
  • University of California at San Diego Moores Cancer Center La Jolla, California, United States
  • University of Colorado Denver Anschultz Medical Campus Aurora, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • The University of Chicago Medical Center (UCMC) Chicago, Illinois, United States
View all 56 locations
View Trial Details
Recruiting

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis

NCT05652335

Conditions
Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +22 more
Locations
  • City of Hope Duarte, California, United States
  • City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
View all 29 locations
View Trial Details
Recruiting

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma

NCT07266441

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • O Neal Comprehensive Cancer Center at UAB Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Duarte, California, United States
  • City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
View all 71 locations
View Trial Details
Recruiting

Actinium Therapy for Late-stage Aggressive Sarcomas

NCT07156565

Conditions
Advanced Soft Tissue Sarcoma, Disease Attributes, Neoplasms, +6 more
Locations
  • UCLA Los Angeles, California, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Memorial Sloane Kettering Cancer Center New York, United States
  • Case Western Cleveland, Ohio, United States
View Trial Details
Recruiting

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

NCT05303519

Conditions
Astrocytoma, Astrocytoma, Grade IV, Astrocytoma, IDH-Mutant, Grade 2, +22 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Mayo Clinic - Arizona Phoenix, Arizona, United States
  • St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • University of California San Diego La Jolla, California, United States
View all 61 locations
View Trial Details
Recruiting

Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma

NCT06375044

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • Dana Farber Cancer institution Boston, Massachusetts, United States
  • Mayo Clinic Rochester Rochester, Minnesota, United States
View all 16 locations
View Trial Details
Recruiting

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

NCT07276399

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +5 more
Locations
  • Ironwood Cancer and Research Center Chandler, Arizona, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Providence St Jude Medical Center Fullerton, California, United States
  • Scripps Health La Jolla, California, United States
View all 201 locations
View Trial Details
Recruiting

Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation

NCT07211958

Conditions
Acute Myeloid Leukemias, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Clinical Trial Site Melbourne, Victoria, Australia
  • Clinical Trial Site Nedlands, Western Australia, Australia
  • Clinical Trial Site Perth, Western Australia, Australia
  • Clinical Trial Site Gosford, Australia
View all 109 locations
View Trial Details

Related conditions